A detailed history of Bray Capital Advisors transactions in Pfizer Inc stock. As of the latest transaction made, Bray Capital Advisors holds 11,028 shares of PFE stock, worth $290,698. This represents 0.08% of its overall portfolio holdings.

Number of Shares
11,028
Previous 11,028 -0.0%
Holding current value
$290,698
Previous $308,000 3.57%
% of portfolio
0.08%
Previous 0.08%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024

SELL
$26.13 - $33.94 $12,150 - $15,782
-465 Reduced 4.05%
11,028 $317,000
Q3 2023

Oct 27, 2023

SELL
$32.09 - $37.51 $124,348 - $145,351
-3,875 Reduced 25.21%
11,493 $381,000
Q2 2023

Jul 28, 2023

SELL
$36.12 - $41.79 $37,998 - $43,963
-1,052 Reduced 6.41%
15,368 $563,000
Q4 2022

Jan 20, 2023

SELL
$41.75 - $54.5 $208,750 - $272,500
-5,000 Reduced 23.34%
16,420 $0
Q3 2022

Nov 21, 2022

BUY
$43.76 - $53.42 $87,520 - $106,840
2,000 Added 10.3%
21,420 $937,000
Q2 2022

Aug 01, 2022

SELL
$46.53 - $55.17 $6,188 - $7,337
-133 Reduced 0.68%
19,420 $1.02 Million
Q1 2022

May 03, 2022

BUY
$45.75 - $56.69 $28,593 - $35,431
625 Added 3.3%
19,553 $1.01 Million
Q2 2021

Jul 28, 2021

BUY
$35.91 - $40.68 $149,924 - $169,839
4,175 Added 28.3%
18,928 $741,000
Q4 2020

Jan 28, 2021

BUY
$33.47 - $42.56 $7,999 - $10,171
239 Added 1.65%
14,753 $543,000
Q1 2020

May 01, 2020

SELL
$27.03 - $38.62 $18,921 - $27,034
-700 Reduced 4.6%
14,514 $474,000
Q4 2019

Jan 31, 2020

BUY
$32.92 - $37.36 $201,470 - $228,643
6,120 Added 67.3%
15,214 $596,000
Q3 2019

Oct 29, 2019

BUY
$32.49 - $42.13 $11,858 - $15,377
365 Added 4.18%
9,094 $327,000
Q2 2019

Jul 29, 2019

BUY
$36.98 - $41.52 $151,544 - $170,148
4,098 Added 88.49%
8,729 $378,000
Q1 2019

Apr 30, 2019

BUY
$37.5 - $41.2 $26,475 - $29,087
706 Added 17.99%
4,631 $197,000
Q1 2018

May 04, 2018

BUY
$31.91 - $37.02 $125,246 - $145,303
3,925 New
3,925 $139,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bray Capital Advisors Portfolio

Follow Bray Capital Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bray Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Bray Capital Advisors with notifications on news.